Patents Assigned to Kurin, Inc.
-
Publication number: 20260182875Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: August 7, 2025Publication date: July 2, 2026Applicant: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Publication number: 20260076597Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: November 21, 2025Publication date: March 19, 2026Applicant: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski
-
Publication number: 20260034312Abstract: Embodiments of needle protectors are disclosed for use with a needle assembly that includes a needle, a housing from which the needle extends, and an actuator for activating a safety mechanism following use of the needle. A needle protector can have a sleeve configured with a lumen sized to accept the needle and a length that extends at least partially over the needle. A cuff can be connected to the sleeve and having a cavity shaped to receive a portion of the housing. An actuator cover can extend from the cuff, opposite the sleeve, and configured to cover the actuator when the needle protector is in place over the needle.Type: ApplicationFiled: June 24, 2025Publication date: February 5, 2026Applicant: Kurin, Inc.Inventors: Nolan Pupping, Kevin Nason, Jeffrey Veloz
-
Publication number: 20250375128Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: August 26, 2025Publication date: December 11, 2025Applicant: Kurin, Inc.Inventors: Bobby E. ROGERS, Gino KANG, David Karl STROUP, Jonas Dean COCHRAN, Arthur DEPTALA, John DETLOFF, Lonnie POGUE, Brian MACOWSKI
-
Patent number: 12390596Abstract: Disclosed are systems that include a syringe having a barrel configured to hold a fluid and a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel. The syringe is configured to inhibit forward movement of the plunger. For example, the systems can include mating pockets configured to engage barbs to inhibit forward movement of the plunger.Type: GrantFiled: March 5, 2024Date of Patent: August 19, 2025Assignee: Kurin, Inc.Inventors: Kevin Nason, Jeffrey Veloz, Bobby E. Rogers, Nolan Pupping
-
Patent number: 12390137Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: September 26, 2024Date of Patent: August 19, 2025Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Publication number: 20250255522Abstract: A fluid sample optimization device for optimizing a fluid sample includes an inlet, an outlet, a sample path connected between the inlet and the outlet, and a contaminant containment reservoir connected between the inlet and the outlet. The contaminant containment reservoir includes an air permeable fluid resistor proximate the outlet, and is arranged to receive, when a pressure differential is applied between the inlet and the outlet, a first portion of the fluid sample to displace air therein through the air permeable fluid resistor and the outlet, such that upon receipt of the first portion of the fluid sample and containment of the contaminants in the contaminant containment reservoir, subsequent portions of the fluid sample can be conveyed by the sample path from the inlet to the outlet when subsequent pressure differentials are applied between the inlet and the outlet.Type: ApplicationFiled: April 22, 2025Publication date: August 14, 2025Applicant: Kurin, Inc.Inventors: Bobby E. ROGERS, Kevin NASON, David Karl STROUP, David G. MATSUURA, Belinko K. MATSUURA
-
Patent number: 12383174Abstract: A fluid sample optimization device for optimizing a fluid sample includes an inlet, an outlet, a sample path connected between the inlet and the outlet, and a contaminant containment reservoir connected between the inlet and the outlet. The contaminant containment reservoir includes an air permeable fluid resistor proximate the outlet, and is arranged to receive, when a pressure differential is applied between the inlet and the outlet, a first portion of the fluid sample to displace air therein through the air permeable fluid resistor and the outlet, such that upon receipt of the first portion of the fluid sample and containment of the contaminants in the contaminant containment reservoir, subsequent portions of the fluid sample can be conveyed by the sample path from the inlet to the outlet when subsequent pressure differentials are applied between the inlet and the outlet.Type: GrantFiled: April 1, 2020Date of Patent: August 12, 2025Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Kevin Nason, David Karl Stroup, David G. Matsuura, Belinko K. Matsuura
-
Patent number: 12357209Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: October 25, 2023Date of Patent: July 15, 2025Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Patent number: 12257051Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: May 15, 2023Date of Patent: March 25, 2025Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski
-
Publication number: 20250049362Abstract: A bodily fluid collection system for collecting a bodily fluid from a patient, and a bodily fluid transfer system for transferring collected bodily fluid to a second collection device. A collection adapter has a connection port configured to securely connect with a hub of a syringe, and a collection interface opposite the connection port creates a fluid conduit to the barrel via the connection port and an inlet of the hub. A proximal adapter is connected to a proximal end of the fluid channel from the patient, and configured to removably interact with the collection interface of the collection adapter to connect the proximal end of the fluid channel to the barrel via the fluid conduit and inlet to the barrel to allow conveyance into the barrel of the at least some of the sampling portion of the sample of bodily fluid. The proximal adapter can be removed to allow access to any bodily fluid collected by the syringe.Type: ApplicationFiled: September 11, 2024Publication date: February 13, 2025Applicant: Kurin, Inc.Inventors: Thomas Thompson, Kevin Nason, Bobby E. Rogers, Jeffrey VELOZ
-
Patent number: 12208260Abstract: Systems, methods, and devices to facilitate insertion of certain leads with electrode(s) into patients are described. Leads can be implanted to work in conjunction with a cardiac pacemaker or cardiac defibrillator. A lead for cardiac therapy may be inserted into an intercostal space associated with the cardiac notch of a patient. Devices for delivery may include, for example, a delivery system coupled with an electrical lead and having a handle, a component advancer and insertion tips. The handle is configured to be actuated by an operator and the component advancer is configured to advance an electrical lead into the patient. The insertion tips can be configured to close around the electrical lead within the component advancer, to push through biological tissue, and to open to enable the lead to advance into the patient. The electrical lead can also be maintained in a particular orientation during the advancement into the patient.Type: GrantFiled: May 29, 2020Date of Patent: January 28, 2025Assignee: Kurin, Inc.Inventors: Rick Sanghera, Matthew Rollins, John Beck, William Born, Shahn Sage, Alan Marcovecchio
-
Publication number: 20250025079Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: September 26, 2024Publication date: January 23, 2025Applicant: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Publication number: 20240374184Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: July 24, 2024Publication date: November 14, 2024Applicant: Kurin, Inc.Inventors: Bobby E. ROGERS, Gino KANG, David Karl STROUP, Jonas Dean COCHRAN, Arthur DEPTALA, John DETLOFF, Lonnie POGUE, Brian MACOWSKI
-
Publication number: 20240374186Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: July 24, 2024Publication date: November 14, 2024Applicant: Kurin, Inc.Inventors: Bobby E. ROGERS, Gino KANG, John DETLOFF
-
Patent number: 12138052Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: July 24, 2024Date of Patent: November 12, 2024Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Publication number: 20240252079Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: October 25, 2023Publication date: August 1, 2024Applicant: Kurin, Inc.Inventors: Bobby E. ROGERS, Gino KANG, John DETLOFF
-
Publication number: 20240198005Abstract: Disclosed are systems that include a syringe having a barrel configured to hold a fluid and a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel. The syringe is configured to inhibit forward movement of the plunger. For example, the systems can include mating pockets configured to engage barbs to inhibit forward movement of the plunger.Type: ApplicationFiled: March 5, 2024Publication date: June 20, 2024Applicant: Kurin, Inc.Inventors: Kevin Nason, Jeffrey Veloz, Bobby E. Rogers, Nolan Pupping
-
Patent number: 11963769Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: November 30, 2021Date of Patent: April 23, 2024Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Publication number: 20240122510Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: May 15, 2023Publication date: April 18, 2024Applicant: KURIN, INC.Inventors: Bobby E. ROGERS, Gino KANG, David Karl STROUP, Jonas Dean COCHRAN, Arthur DEPTALA, John DETLOFF, Lonnie POGUE, Brian MACOWSKI